市場調查報告書
商品編碼
1471172
白血球分離術市場:按類型、應用和最終用戶分類 - 全球預測,2024-2030 年Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年Leucafferesis市場規模為5,621萬美元,2024年達6,162萬美元,預計2030年將達到1,0758萬美元,複合年成長率為9.71%。
白血球去除術包括與從患者或捐贈者的血液中選擇性去除白血球(白血球)相關的產品、設備、程序和服務。它包括不同類型的白血球分離術,例如自體血球移植和同種異體血球移植,並應用於癌症治療、造血幹細胞移植(HSCT)、慢性發炎疾病管理和免疫系統調節等各個治療領域。由於對老齡化相關疾病的易感性增加,不斷擴大的老年人口增加了對白血球去除術治療的需求。然而,與白血球分離術所需的設備和消耗品相關的高成本對患者和醫療保健提供者構成了重大障礙。然而,將白血球分離衍生的細胞應用於再生醫學和其他應用的臨床試驗正在進行中,為白血球分離市場創造了潛力。
主要市場統計 | |
---|---|
基準年[2023] | 5621萬美元 |
預測年份 [2024] | 6162萬美元 |
預測年份 [2030] | 10758萬美元 |
複合年成長率(%) | 9.71% |
類型:更多地使用白血球分離裝置來有效分離白血球
白血球分離設備是用於在各種醫療應用中從捐贈者或患者血液中分離白血球的專用設備,包括癌症研究、細胞療法開發和臨床輸血。這些設備旨在確保高品質的細胞分離,同時最大限度地減少對收穫細胞的損害。離心白血球分離裝置利用離心原理,根據白血球的密度來分離白血球。膜分離器使用多孔膜根據白血球和其他血液成分的大小分離它們。白血球分離術拋棄式是白血球分離術過程中使用的一次性無菌組件,用於在細胞收集和分離過程中保持無菌。包括單採套件、管組、過濾器、收集袋等。
應用:白血球去除術在治療上的應用越來越多,以改善患者的治療效果。
對於研究應用,白血球分離術透過分離白血球和進行高品質的樣本分析,促進血癌、幹細胞研究和免疫學研究。白血球分離術在研究應用中的使用越來越多,主要是因為它能夠提供純淨和濃縮的樣品,從而改善實驗結果並產生準確的結果。在治療方面,白血球分離術在各種醫療程序中發揮重要作用,包括造血幹細胞移植 (HSCT)、CAR-T 細胞治療、移植醫學和自體免疫疾病管理。治療應用可以提供臨床益處,例如透過去除多餘的白血球或促進標靶細胞治療來降低疾病嚴重程度並改善患者預後。
最終用戶:血液成分提供者和血液中心擴大白血球分離裝置的使用
學術和研究機構致力於研究白血球在各種疾病中的作用並開發新的治療策略。血液成分供應商和血液中心需要有效的白血球分離設備來分離輸血和治療目的所需的特定血液成分。合約研究委外研發機構(CRO) 需要白血球分離術產品和服務來代表製藥和生物技術公司支援臨床試驗和藥物開發流程。醫院和輸血中心需要白血球分離裝置來治療性地減少白血病和其他血液疾病患者的白血球。製藥和生物技術公司正在投資先進的白血球分離設備,以支援與免疫系統相關的各種疾病和病症的新藥的研發。
區域洞察
由於強大的醫療基礎設施、白血病盛行率的增加以及先進技術的採用,美洲白血球去除術市場正在發展。在歐盟 (EU),血液疾病的增加增加了對白血球分離產品的需求。在歐洲、中東和非洲,人們對白血病治療方案認知的提高和醫療基礎設施的改善正在推動對白血球去除術產品的需求。在亞太地區,由於醫療保健成本不斷上升、人們對血液疾病的認知不斷提高以及醫療技術的進步,白血球清除術市場正在顯著成長。白血球分離裝置的進步預計也將改善治療效果並加速全球最終用途領域的部署。
FPNV定位矩陣
FPNV 定位矩陣對於評估白血球去除術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對 Leucafferesis 市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動和突破性產品開發的智力見解。
1.Leucafferesis市場的市場規模和預測是多少?
2.在Leucafferesis市場的預測期內,我們應該考慮投資哪些產品和應用?
3.白血球分離術市場的技術趨勢和法規結構是什麼?
4.Leucafferesis市場主要供應商的市場佔有率是多少?
5. 進入Leucaferesis市場的適當形式和策略手段是什麼?
[190 Pages Report] The Leukapheresis Market size was estimated at USD 56.21 million in 2023 and expected to reach USD 61.62 million in 2024, at a CAGR 9.71% to reach USD 107.58 million by 2030.
The leukapheresis includes the products, devices, procedures, and services related to selectively removing white blood cells (leukocytes) from a patient's or donor's blood. It encompasses different types of leukapheresis procedures, such as autologous leukapheresis and allogeneic leukapheresis, which are applied across various therapeutic areas, including cancer treatment, hematopoietic stem cell transplantation (HSCT), chronic inflammatory diseases management, and immune system regulation. The expanding geriatric population increases the demand for leukapheresis treatments due to their increased susceptibility to age-related diseases. However, the high costs associated with devices and consumables necessary for leukapheresis pose significant barriers for patients and healthcare providers. Nevertheless, ongoing clinical trials exploring novel applications of leukapheresis-derived cells in areas including regenerative medicine present potential opportunities for the leukapheresis market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 56.21 million |
Estimated Year [2024] | USD 61.62 million |
Forecast Year [2030] | USD 107.58 million |
CAGR (%) | 9.71% |
Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
Leukapheresis devices are specialized equipment used to separate white blood cells from the blood of donors or patients for various medical applications such as cancer research, cell therapy development, or clinical transfusions. These devices are designed to ensure high-quality cell separation with minimal damage to the collected cells. The centrifugal leukapheresis devices use the principles of centrifugation to separate white blood cells based on their density. Membrane separators use porous membranes to separate leukocytes from other blood components based on their size. Leukapheresis disposables are single-use, sterile components used in the leukapheresis procedure to maintain aseptic conditions during cell collection and separation. These include apheresis kits, tubing sets, filters, and collection bags.
Application: Rising application of leukapheresis in therapeutics for improved patient outcome
In research applications, leukapheresis facilitates studying blood cancer types, stem cell research, and immunology by isolating white blood cells for high-quality sample analysis. The increasing use of leukapheresis in research applications arises primarily due to its ability to provide pure and concentrated samples that can improve experimental outcomes and facilitate accurate results. Therapeutically, leukapheresis has significant use in various medical procedures, including hematopoietic stem cell transplantation (HSCT), CAR-T cell therapy, transplantation medicine, and autoimmune disease management. Therapeutic applications provide clinical benefits such as reduced disease severity and improved patient outcomes by removing excess WBCs or facilitating targeted cellular therapies.
End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
Academic and research Institutes focus on investigating the role of leukocytes in various diseases and developing new therapeutic strategies. Blood component providers and blood centers require effective leukapheresis devices to separate specific blood components needed for transfusions or therapeutic purposes. Contract Research Organizations (CROs) require leukapheresis products and services to support clinical trials and drug development processes on behalf of pharmaceutical and biotechnology companies. Hospitals and transfusion centers need leukapheresis devices to treat patients with leukemia or other hematological disorders through therapeutic leukocyte reduction. Pharmaceutical and biotechnology companies invest in advanced leukapheresis devices to support their research and development of new drugs targeting various diseases or conditions related to the immune system.
Regional Insights
The leukapheresis market is evolving in the Americas with robust healthcare infrastructure, increasing prevalence of leukemia, and adoption of advanced technologies. The European Union (EU) has shown a growing demand for leukapheresis products due to rising incidences of blood disorders. In the EMEA region, increased awareness about leukemia treatment options and improved healthcare infrastructure drive demand for leukapheresis products. The Asia Pacific region represents significant growth in the leukapheresis market due to increased healthcare expenditure, growing awareness of blood disorders, and advancements in healthcare technology. Besides, advancements in leukapheresis devices are anticipated to improve treatment outcomes and encourage their deployment across end-use sectors globally.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Leukapheresis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leukapheresis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Leukapheresis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leukapheresis Market?
3. What are the technology trends and regulatory frameworks in the Leukapheresis Market?
4. What is the market share of the leading vendors in the Leukapheresis Market?
5. Which modes and strategic moves are suitable for entering the Leukapheresis Market?